☰

Ping Mu

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Area:
Cancer Biology
Google:
"Ping Mu"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Charles Sawyers post-doc 2013-2018 Memorial Sloan Kettering Cancer Center

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rodriguez Tirado C, Wang C, Li X, et al. (2023) UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance. Oncogene
Xu Y, Wang Z, Sjöström M, et al. (2023) ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers. Biorxiv : the Preprint Server For Biology
Li X, Mu P. (2023) The Critical Interplay of CAF Plasticity and Resistance in Prostate Cancer. Cancer Research
Li X, Wang Y, Deng S, et al. (2023) Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. Cancer Cell
Deng S, Wang C, Wang Y, et al. (2022) Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nature Cancer
Lo UG, Chen YA, Cen J, et al. (2022) The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer. Clinical and Translational Medicine. 12: e978
Chen L, Mu B, Li Y, et al. (2022) DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression. Pediatric Research
de Wet L, Williams A, Gillard M, et al. (2022) Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 41: 1234
de Wet L, Williams A, Gillard M, et al. (2022) SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene
Blatt EB, Kopplin N, Kumar S, et al. (2020) Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview. Endocrine-Related Cancer
See more...